New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...
NEEDHAM, MA, UNITED STATES, February 10, 2026 /EINPresswire.com/ — Trialt, a global clinical research organization (CRO) specializing in biostatistics, statistical ...
NEW YORK, Feb. 10, 2026 /PRNewswire/ -- ObvioHealth and Oracle Health and Life Sciences today announced that ObvioGo® is now directly integrated with Oracle Health and Life Sciences Clinical One Data ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results